mdlinx mdlinx

Pharmacy - Major Studies News & Articles

MDLinx Pharmacy - Major Studies helps physicians and healthcare professionals stay up to date with the latest pharmacy - major studies news articles and research, as well as pharmacy - major studies jobs, conferences, and resources.

Your Unread Messages in Pharmacy

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (3) Full Text Articles (19)
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

361 Intima-medial thickness homogeneity in the common carotid artery: Measurement method and preliminary clinical study Journal of Clinical Ultrasound, September 14, 2012

362 American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide Takeda Pharmaceuticals U.S.A., September 6, 2012    Clinical Article

363 An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients BMC Nephrology, September 4, 2012    Clinical Article

364 The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics Clinical Pharmacology & Therapeutics, August 30, 2012

365 New data from Phase III EMILIA study showed Roche’s trastuzumab emtansine (T-DM1) significantly improved survival of people with HER2-positive metastatic breast cancer Full Text Roche, August 28, 2012    Clinical Article

366 Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305 Epilepsia, August 22, 2012    Clinical Article

367 A phase 1 study to evaluate dolutegravir's effect on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects British Journal of Clinical Pharmacology, August 22, 2012    Clinical Article

368 Potentially inappropriate drug use among older persons in Finland: application of a new national categorization European Journal of Clinical Pharmacology, August 20, 2012    Clinical Article

369 Phase III Results Published in NEJM Show Ocriplasmin Could Be First Pharmacological Eye Treatment for Vitreomacular Adhesion Patients Alcon, August 16, 2012

370 Relationship between telmisartan dose and glycaemic control in japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study Clinical Drug Investigation, August 14, 2012    Clinical Article

371 A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study HIV Clinical Trials, August 7, 2012    Clinical Article

372 Cortical remyelination: A new target for repair therapies in multiple sclerosis Annals of Neurology , August 1, 2012    Clinical Article

373 Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews European Journal of Clinical Pharmacology, August 1, 2012

374 Identifying risky behaviors: the key to HIV prevention Neurotherapeutics, July 31, 2012

375 Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study Leukemia, July 30, 2012    Clinical Article

376 New developments in the treatment of osteoporosis. Acta Obstetricia et Gynecologica Scandinavica, July 27, 2012    Clinical Article

377 New drugs for the treatment of tuberculosis: hope and reality The International Journal of Tuberculosis and Lung Disease, July 25, 2012    Clinical Article

378 Gilead's hiv integrase inhibitor elvitegravir dosed once daily as effective as twice-daily raltegravir over two years of therapy in pivotal phase 3 study Full Text Gilead, July 25, 2012

379 Gilead's once-daily single tablet regimen complera maintains hiv suppression among patients switching from protease inhibitor-based regimens Full Text Gilead, July 25, 2012

380 Gilead's boosting agent cobicistat for hiv therapy as effective as ritonavir in pivotal phase 3 study Full Text Gilead, July 25, 2012

50 available pages First Previous 19 20 21 22 23 24 25 26 27 28 Next Last

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Pharmacy Articles

Last month's top read Top Articles of 2012

1 To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 12, 2013    Review Article

2 Green coffee bean extract for weight loss American Pharmacists Association News, March 15, 2013    Free full text

3 Leakage from closed-system transfer devices as detected by a radioactive tracer American Journal of Health-System Pharmacy, April 1, 2013    Review Article

4 PPIs May Provide Solution for Questionable Aspirin Allergies Pharmacy Times, March 21, 2013    Free full text    Review Article

5 Divide the Dose for Round-the-Clock Aspirin Coverage in Diabetes Patients Pharmacy Times, April 26, 2013    Free full text

6 FDA Drug Safety Podcasts: Resources for drug information Journal of the American Pharmacists Association, April 17, 2013    Free full text    Review Article

7 Do Sugar Substitutes Have Any Impact on Glycemic Control in Patients with Diabetes? Journal of Pharmacy Technology, April 15, 2013

8 Vitamin D does not reduce osteoarthritis knee pain, progression Formulary , March 1, 2013    Free full text

9 High Doses, Long Durations: Veterans and GERD Treatments Pharmacy Times, April 26, 2013    Free full text    Review Article

10 High calcium intake linked to CVD in women Formulary , March 19, 2013    Free full text    Review Article

11 Evolving Therapeutic Targets in Ischemic Stroke: A Concise Review Current Drug Targets, April 16, 2013    Review Article

12 Poor Sleep Patterns May Signal Alzheimers Pharmacy Times, April 26, 2013    Free full text

13 A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM) European Journal of Clinical Pharmacology, April 1, 2013    Review Article

14 Case-Control Study of Drug Monitoring of {beta}-Lactams in Obese Critically Ill Patients Antimicrobial Agents and Chemotherapy, February 6, 2013    Review Article

15 Phosphate: an old bone molecule but new cardiovascular risk factor British Journal of Clinical Pharmacology, April 1, 2013    Review Article

16 Pharmacology of Iron Transport Annual Review of Pharmacology and Toxicology, March 14, 2013    Review Article

17 Multiple Phytoestrogens Inhibit Cell Growth and Confer Cytoprotection By Inducing Manganese Superoxide Dismutase Expression Phytotherapy Research, April 8, 2013    Review Article

18 Immune classification of colorectal cancer patients: impressive but how complete? Expert Opinion on Biological Therapy, March 22, 2013    Review Article

19 Progress in the studies on tryptanthrin, an alkaloid of history Archives of Pharmacal Research, April 5, 2013    Free full text    Review Article

20 Aspirin May Help Prevent Melanoma Pharmacy Times, April 26, 2013    Free full text    Review Article

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close